UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nedaplatin: a cisplatin derivative in cancer chemotherapy

Cancer management and research, 2013, Vol.5 (default), p.67-76

2013

Volltextzugriff (PDF)

Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging

British journal of cancer, 2006-05, Vol.94 (10), p.1369-1374

2006

Volltextzugriff (PDF)

Low response rate of second‐line chemotherapy for recurrent or refractory clear cell carcinoma of the ovary: a retrospective Japan Clear Cell Carcinoma Study

International journal of gynecological cancer, 2008-09, Vol.18 (5), p.937-942

2008

Volltextzugriff (PDF)

Correlation between Loss of PTEN Expression and Akt Phosphorylation in Endometrial Carcinoma

Clinical cancer research, 2001-04, Vol.7 (4), p.892-895

2001

Volltextzugriff (PDF)

Galectin‐3 may contribute to Cisplatin resistance in clear cell carcinoma of the ovary

International journal of gynecological cancer, 2007-09, Vol.17 (5), p.1040-1046

2007

Volltextzugriff (PDF)

Expression of hypoxia‐inducible factor 1α gene affects the outcome in patients with ovarian cancer

International journal of gynecological cancer, 2008-05, Vol.18 (3), p.499-505

2008

Volltextzugriff (PDF)

Comparison of adjuvant chemotherapy and radiotherapy in patients with cervical adenocarcinoma of the uterus after radical hysterectomy: SGSG/TGCU Intergroup surveillance

European journal of gynaecological oncology, 2013, Vol.34 (5), p.425-428

2013

Volltextzugriff (PDF)

Prognosis and clinicopathological characteristics of Ib-IIb adenocarcinoma of the uterine cervix in patients who have had radical hysterectomy

European journal of surgical oncology, 2000-08, Vol.26 (5), p.464-467

2000

Volltextzugriff (PDF)

Chemosensitivity and p53–Bax pathway-mediated apoptosis in patients with uterine cervical cancer

Annals of oncology, 2003-02, Vol.14 (2), p.214-219

2003

Volltextzugriff (PDF)

Genetic diagnosis for chemosensitivity with drug‐resistance genes in epithelial ovarian cancer

International journal of gynecological cancer, 2007-01, Vol.17 (1), p.76-82

2007

Volltextzugriff (PDF)

The first study evaluating the distribution of gBRCA1/2 variants within the ovarian cancer cluster region in Japanese ovarian cancer patients

Gynecologic oncology, 2020-10, Vol.159, p.342-342

2020

Volltextzugriff (PDF)

The first nationwide Japanese multicenter study: Characterizing the cross-sectional approach to ovarian cancer genetic testing of BRCA (CHARLOTTE)

Gynecologic oncology, 2019-06, Vol.154, p.31-31

2019

Volltextzugriff (PDF)

The first nationwide Japanese multicenter study: Characterizing the cross-sectional approach to ovarian cancer genetic testing of (CHARLOTTE)

Gynecologic oncology, 2019-06, Vol.154, p.31

2019

Volltextzugriff (PDF)

Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta

Drug metabolism and disposition, 2005-01, Vol.33 (1), p.94-101

2005

Volltextzugriff (PDF)

Japan CHARLOTTE: Characterizing the cross-sectional approach to ovarian cancer: Genetic testing of BRCA

Annals of oncology, 2017-09, Vol.28, p.v350-v350

2017

Volltextzugriff (PDF)

Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene

The Journal of pharmacology and experimental therapeutics, 2001-06, Vol.297 (3), p.1137

2001

Volltextzugriff (PDF)

Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy

Cancer, 2000-06, Vol.88 (11), p.2584-2589

2000

Volltextzugriff (PDF)

Loss of ARID1A expression is associated with poor prognosis in patients with stage I/II clear cell carcinoma of the ovary

Annals of oncology, 2016-10, Vol.27, p.vi303-vi303

2016

Volltextzugriff (PDF)

Gamma-glutamyl cysteine synthetase up-regulates glutathione and multidrug resistance-associated protein in patients with chemoresistant epithelial ovarian cancer

Clinical cancer research, 1998-07, Vol.4 (7), p.1737-1741

1998

Volltextzugriff (PDF)

p53 gene status and chemosensitivity in ovarian cancer

Human cell : official journal of Human Cell Research Society, 2001-09, Vol.14 (3), p.165-171

2001

Volltextzugriff (PDF)

Outcome of patients with early ovarian cancer undergoing three courses of adjuvant chemotherapy following complete surgical staging

International journal of gynecological cancer, 2005-07, Vol.15 (4), p.601-605

2005

Volltextzugriff (PDF)

Effect of simple omentoplasty and omentopexy in the prevention of complications after pelvic lymphadenectomy

International journal of gynecological cancer, 2003-01, Vol.13 (1), p.61-66

2003

Volltextzugriff (PDF)

Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials

European journal of cancer (1990), 2003-11, Vol.39 (17), p.2470-2486

2003

Volltextzugriff (PDF)

Low proliferation activity may be associated with chemoresistance in clear cell carcinoma of the ovary

Obstetrics and gynecology (New York. 1953), 2002-08, Vol.100 (2), p.281-287

2002

Volltextzugriff (PDF)

Phase I trial of paclitaxel, doxorubicin, and carboplatin (TAC) for the treatment of endometrial cancer

International journal of gynecological cancer, 2007-01, Vol.17 (1), p.210-214

2007

Volltextzugriff (PDF)

1 – 25 von 185

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(168)
Mit Volltextzugriff
(141)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(113)
Science & Technology
(106)
Female
(104)
Life Sciences & Biomedicine
(104)
Biological And Medical Sciences
(64)
Medical Sciences
(63)
Middle Aged
(62)
Oncology
(58)
Adult
(56)
Aged
(51)
Ovarian Neoplasms - Drug Therapy
(39)
Obstetrics & Gynecology
(34)
Tumors
(33)
Female Genital Diseases
(30)
Gynecology. Andrology. Obstetrics
(30)
Chemotherapy
(29)
Ovarian Cancer
(28)
Ovarian Neoplasms - Pathology
(28)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(27)
Pharmacology. Drug Treatments
(25)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Nedaplatin: a cisplatin derivative in cancer chemotherapy

Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging

Low response rate of second‐line chemotherapy for recurrent or refractory clear cell carcinoma of the ovary: a retrospective Japan Clear Cell Carcinoma Study

Correlation between Loss of PTEN Expression and Akt Phosphorylation in Endometrial Carcinoma

Galectin‐3 may contribute to Cisplatin resistance in clear cell carcinoma of the ovary

Expression of hypoxia‐inducible factor 1α gene affects the outcome in patients with ovarian cancer

Comparison of adjuvant chemotherapy and radiotherapy in patients with cervical adenocarcinoma of the uterus after radical hysterectomy: SGSG/TGCU Intergroup surveillance

Prognosis and clinicopathological characteristics of Ib-IIb adenocarcinoma of the uterine cervix in patients who have had radical hysterectomy

Chemosensitivity and p53–Bax pathway-mediated apoptosis in patients with uterine cervical cancer

Genetic diagnosis for chemosensitivity with drug‐resistance genes in epithelial ovarian cancer

The first study evaluating the distribution of gBRCA1/2 variants within the ovarian cancer cluster region in Japanese ovarian cancer patients

The first nationwide Japanese multicenter study: Characterizing the cross-sectional approach to ovarian cancer genetic testing of BRCA (CHARLOTTE)

The first nationwide Japanese multicenter study: Characterizing the cross-sectional approach to ovarian cancer genetic testing of (CHARLOTTE)

Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta

Japan CHARLOTTE: Characterizing the cross-sectional approach to ovarian cancer: Genetic testing of BRCA

Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene

Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy

Loss of ARID1A expression is associated with poor prognosis in patients with stage I/II clear cell carcinoma of the ovary

Gamma-glutamyl cysteine synthetase up-regulates glutathione and multidrug resistance-associated protein in patients with chemoresistant epithelial ovarian cancer

p53 gene status and chemosensitivity in ovarian cancer

Outcome of patients with early ovarian cancer undergoing three courses of adjuvant chemotherapy following complete surgical staging

Effect of simple omentoplasty and omentopexy in the prevention of complications after pelvic lymphadenectomy

Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials

Low proliferation activity may be associated with chemoresistance in clear cell carcinoma of the ovary

Phase I trial of paclitaxel, doxorubicin, and carboplatin (TAC) for the treatment of endometrial cancer

Suchergebnisse filtern